Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Generation and characterization of a human induced pluripotent stem (iPS) cell line derived from an acute myeloid leukemia patient evolving from primary myelofibrosis carrying the CALR 52bp deletion and the ASXL1 p.R693X mutation.
Gomez Limia CE, Devalle S, Reis M, Sochacki J, Carneiro M, Madeiro da Costa R, D'Andrea M, Padilha T, Zalcberg IR, Solza C, Daumas A, Rehen S, Monte-Mór B, Bonamino MH. Gomez Limia CE, et al. Among authors: solza c. Stem Cell Res. 2017 Oct;24:16-20. doi: 10.1016/j.scr.2017.08.006. Epub 2017 Aug 8. Stem Cell Res. 2017. PMID: 29034885 Free article.
Characterization of a human induced Pluripotent Stem (iPS) cell line (INCABRi002-A) derived from a primary myelofibrosis patient harboring the 5-bp insertion in CALR and the p.W146X mutation in TP53.
Gomez Limia CE, Devalle S, Reis M, Sochacki J, Madeiro da Costa R, D'Andrea M, Padilha T, Zalcberg IR, Solza C, Daumas A, Rehen S, Bonamino MH, Monte-Mór B. Gomez Limia CE, et al. Among authors: solza c. Stem Cell Res. 2018 Dec;33:130-134. doi: 10.1016/j.scr.2018.09.012. Epub 2018 Sep 20. Stem Cell Res. 2018. PMID: 30343103 Free article.
Clinical features of JAK2V617F- or CALR-mutated essential thrombocythemia and primary myelofibrosis.
Monte-Mor Bda C, Ayres-Silva Jde P, Correia WD, Coelho AC, Solza C, Daumas AH, Bonamino MH, Santos FP, Datoguia TS, Pereira Wde O, Lisboa BC, Ramos CF, Machado-Neto JA, Hamerschlak N, Campregher PV, Traina F, Pagnano KB, Zalcberg I. Monte-Mor Bda C, et al. Among authors: solza c. Blood Cells Mol Dis. 2016 Sep;60:74-7. doi: 10.1016/j.bcmd.2016.03.003. Epub 2016 Mar 8. Blood Cells Mol Dis. 2016. PMID: 26994960 Clinical Trial. No abstract available.
JAK2 V617F allele burden quantified by real time quantitative polymerase chain reaction and competitive polymerase chain reaction in patients with chronic myeloproliferative neoplasia.
Kaeda J, Bonamino M, Ayres-Silva J, Solza C, Ringel F, Blau O, Daumas A, Oberender C, Dörken B, le Coutre P, Zalcberg I. Kaeda J, et al. Among authors: solza c. Leuk Lymphoma. 2014 Jan;55(1):128-35. doi: 10.3109/10428194.2013.797085. Epub 2013 Jun 5. Leuk Lymphoma. 2014. PMID: 23607255
Treatment outcomes for Hodgkin lymphoma: First report from the Brazilian Prospective Registry.
Biasoli I, Castro N, Delamain M, Silveira T, Farley J, Simões BP, Solza C, Praxedes M, Baiocchi O, Gaiolla R, Franceschi F, Sola CB, Boquimpani C, Clementino N, Perini G, Pagnano K, Steffenello G, Tabacof J, de Freitas Colli G, Soares A, de Souza C, Chiattone CS, Milito C, Morais JC, Spector N. Biasoli I, et al. Among authors: solza c. Hematol Oncol. 2018 Feb;36(1):189-195. doi: 10.1002/hon.2450. Epub 2017 Jun 23. Hematol Oncol. 2018. PMID: 28643458
22 results